drug

gentulizumab

Preclinicalupdated 3mo ago

by Changchun High-Tech Industry Group Co Ltd

Preclinical

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying gentulizumab

phase1Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrometerminatedn=58
phase1Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphomaterminatedn=58

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 43m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

gentulizumab

Preclinicalupdated 3mo ago

by Changchun High-Tech Industry Group Co Ltd

Preclinical

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying gentulizumab

phase1Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrometerminatedn=58
phase1Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphomaterminatedn=58

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 43m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

gentulizumab

all catalysts(0)

Trials studying gentulizumab

News(0)

Report a data issue

comments(0)

gentulizumab

all catalysts(0)

Trials studying gentulizumab

News(0)

Report a data issue

comments(0)